Arkolith/Insider Trading/CATX/Form 4

Williamson Robert F III

DirectorPerspective Therapeutics, Inc. (CATX) · full profile →Form 4 · filed Dec 19, 2023
Net Buying
Open-Market Buys
$7K
Open-Market Sells
$0
Net Open-Market Flow
$7K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2023Buy(P)14K$0.32$4K24K
Dec 18, 2023Buy(P)10K$0.26$3K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-23-034933) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML